The Use of Glucocorticoids for Better Control of Diabetes Mellitus: The Paradox of Sclerosing Mesenteritis (The Rare Could Become Common)

Beata Mrozikiewicz-Rakowska; Mateusz Zygmunciak; Tomasz Głażewski; Mateusz Mieczkowski; Joanna Podgórska; Olgierd Rowiński; Leszek Czupryniak

doi:10.12659/AJCR.930453

31 May 2021 : Case report Poland

The Use of Glucocorticoids for Better Control of Diabetes Mellitus: The Paradox of Sclerosing Mesenteritis (The Rare Could Become Common)

Challenging differential diagnosis, Unusual or unexpected effect of treatment, Rare disease

Beata Mrozikiewicz-Rakowska^1ABCDEF, Mateusz Zygmunciak^1ABCDEF*, Tomasz Głażewski^1AB, Mateusz Mieczkowski^1CDE, Joanna Podgórska^2CDE, Olgierd Rowiński^2DE, Leszek Czupryniak^3DEF

DOI: 10.12659/AJCR.930453

Am J Case Rep 2021; 22:e930453

Authors information Article notes Copyright and License information

Background Case Report Discussion Conclusions References:

Related articles Order reprints Share article Share by email

View HTML version

Figure 1. Contrast-enhanced T1 GRE fat-saturated image shows a well-demarcated mass-like lesion in the mesentery with the presence of a capsule (open arrows) and spared fat around traversing vessels (white arrows). The image strongly suggests sclerosing mesenteritis.

Back to the Article

The Use of Glucocorticoids for Better Control of Diabetes Mellitus: The Paradox of Sclerosing Mesenteritis (The Rare Could Become Common)

Your Privacy